Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2352 USD | +0.09% | -3.76% | -26.25% |
May. 14 | Transcript : Asensus Surgical, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (ASXC) ASENSUS SURGICAL Posts Q1 Revenue $1.1M, vs. Street Est of $1.2M | MT |
Financials (USD)
Sales 2024 * | 12.06M | Sales 2025 * | 21.91M | Capitalization | 64M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -61M | EV / Sales 2024 * | 5.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
-0.98
x | P/E ratio 2025 * |
-1.24
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.95% |
Latest transcript on Asensus Surgical, Inc.
1 week | -3.76% | ||
Current month | -4.62% | ||
1 month | -5.92% | ||
3 months | -21.60% | ||
6 months | -12.89% | ||
Current year | -26.25% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Fernando
CEO | Chief Executive Officer | 52 | 15-07-31 |
Director of Finance/CFO | 57 | 20-08-23 | |
Motti Frimer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 04-12-31 | |
Kevin Hobert
BRD | Director/Board Member | 59 | 21-07-21 |
William Starling
FOU | Founder | 70 | 98-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 0.2352 | +0.09% | 483 225 |
24-05-28 | 0.235 | -2.49% | 1,202,189 |
24-05-24 | 0.241 | -1.39% | 1,012,512 |
24-05-23 | 0.2444 | 0.00% | 532,141 |
24-05-22 | 0.2444 | -1.45% | 884,374 |
Delayed Quote Nyse, May 29, 2024 at 03:15 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.25% | 64M | |
-8.34% | 177B | |
-0.69% | 108B | |
-7.36% | 65.55B | |
+2.64% | 50.66B | |
+6.38% | 42.58B | |
+5.73% | 40.74B | |
+18.13% | 31.07B | |
+16.57% | 25.45B | |
-5.68% | 23.93B |
- Stock Market
- Equities
- ASXC Stock